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Abstract. 
 
Tubulin is a heterodimer of 
 
a
 
- and 
 
b
 
-tubulin 
polypeptides. Assembly of the tubulin heterodimer in 
vitro requires the CCT chaperonin complex, and a set 
of five proteins referred to as the tubulin cofactors 
(Tian, F., Y. Huang, H. Rommelaere, J. Vandekerck-
hove, C. Ampe, and N.J. Cowan. 1996. 
 
Cell.
 
 86:287—296; 
Tian, G., S.A. Lewis, B. Feierbach, T. Stearns, H. Rom-
melaere, C. Ampe, and N.J. Cowan. 1997. 
 
J. Cell Biol.
 
 
138:821—832). We report the characterization of Alf1p, 
the yeast ortholog of mammalian cofactor B. Alf1p in-
teracts with 
 
a
 
-tubulin in both two-hybrid and immuno-
precipitation assays. Alf1p and cofactor B contain a
single CLIP-170 domain, which is found in several
microtubule-associated proteins. Mutation of the 
CLIP-170 domain in Alf1p disrupts the interaction with 
 
a
 
-tubulin. Mutations in 
 
a
 
-tubulin that disrupt the inter-
action with Alf1p map to a domain on the cytoplasmic 
face of 
 
a
 
-tubulin; this domain is distinct from the region 
of interaction between 
 
a
 
-tubulin and 
 
b
 
-tubulin. Alf1p-
green fluorescent protein (GFP) is able to associate 
with microtubules in vivo, and this localization is abol-
ished either by mutation of the CLIP-170 domain in 
Alf1p, or by mutation of the Alf1p-binding domain in 
 
a
 
-tubulin. Analysis of double mutants constructed be-
tween null alleles of 
 
ALF1
 
 and 
 
PAC2
 
, which encodes 
the other yeast 
 
a
 
-tubulin cofactor, suggests that Alf1p 
and Pac2p act in the same pathway leading to func-
tional 
 
a
 
-tubulin. The phenotype of overexpression of 
 
ALF1
 
 suggests that Alf1p can act to sequester 
 
a
 
-tubu-
lin from interaction with 
 
b
 
-tubulin, raising the possibil-
ity that it plays a regulatory role in the formation of the 
tubulin heterodimer.
Key words: tubulin ¥ microtubule ¥ 
 
Saccharomyces 
cerevisiae
 
 ¥ chaperonin ¥ CLIP-170
M
 
ICROTUBULES
 
 are essential and ubiquitous cy-
toskeletal elements composed of heterodimers
of 
 
a
 
- and 
 
b
 
-tubulin. Much of the work on micro-
tubules has focused on the requirements for polymeriza-
tion of the 
 
a
 
-
 
b
 
 heterodimer into microtubules, and the
temporal and spatial regulation of that polymerization.
Less well understood are the steps leading to formation of
the 
 
a
 
-
 
b
 
 heterodimer in the cell, including regulation of the
amounts of individual subunits, folding of the 
 
a
 
- and 
 
b
 
-tubu-
lin monomeric subunits, and assembly of the monomers
into heterodimers.
For many proteins, folding into the correct three-dimen-
sional structure occurs spontaneously, driven by primary
sequence determinants, as demonstrated for ribonuclease
A by Anfinsen (Anfinsen, 1973). However the tubulins do
not fold spontaneously and require the action of cytosolic
chaperonin (c-cpn; also referred to as TRiC or Cct com-
plex; Frydman et al., 1992; Yaffe et al., 1992; Gao et al.,
1993; Stoldt et al., 1996), a multisubunit toroidal complex
that generates potentially productive folding intermedi-
ates via multiple rounds of ATP-hydrolysis (for review,
see Hendrick and Hartl, 1995). The known in vivo sub-
strates of c-cpn include actin, and 
 
a
 
-, 
 
b
 
-, and 
 
g
 
-tubulin
(Frydman et al., 1992; Gao et al., 1992; Melki et al., 1993;
Sternlicht et al., 1993). In in vitro reactions that use dena-
tured protein as the starting material, both actin and 
 
g
 
-tubu-
lin are fully functional after interaction with the c-cpn
(Gao et al., 1992; Melki et al., 1993), but 
 
a
 
- and 
 
b
 
-tubulin
must interact with several additional proteins before they
form a heterodimer that is competent for assembly into
microtubules (Gao et al., 1993). This observation led to
the purification and characterization of the mammalian
cofactors (A through E) for tubulin formation (Tian et al.,
1996, 1997). It has been proposed that the known cofactors
interact with partially folded 
 
a
 
- and 
 
b
 
-tubulin and bring
about their successful folding and subsequent joining to
form the heterodimer. This would occur by a set of se-
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quential interactions, the early steps of which are separate
for 
 
a
 
- and 
 
b
 
-tubulin (Tian et al., 1996, 1997; also, see Fig.
8). Cofactors A and D are specific for 
 
b
 
-tubulin, whereas
cofactors B and E are specific for 
 
a
 
-tubulin, and the order
of action of the cofactors has been determined biochemi-
cally with purified proteins (Tian et al., 1997).
Cofactors A, B, D, and E each have a putative homo-
logue in the 
 
Saccharomyces cerevisiae
 
 genome, and genetic
experiments have helped to define the in vivo role of the
cofactors. 
 
RBL2
 
, the homologue of cofactor A, was identi-
fied as a gene that when overexpressed is able to compen-
sate for the lethality of 
 
b
 
-tubulin overexpression (Archer
et al., 1995). 
 
ALF1
 
, the homologue of cofactor B, was
identified by sequence homology (Tian et al., 1997). 
 
CIN1
 
,
the homologue of cofactor D, was identified as a mutant
with reduced fidelity of chromosome segregation and in-
 
Table I. Yeast Strains
 
Strain Genotype Source
 
TSY678
 
MATa
 
 
 
alf1::HIS3 ade2-101 his3
 
D
 
-200 ura3-52 lys2-801 leu2-3,-112
 
This study
TSY679
 
MATa
 
 
 
alf1::HIS3 his3
 
D
 
-200 ura3-52 lys2-801 leu2-3,-112
 
This study
TSY680
 
MATa
 
 
 
alf1::URA3 ade2-101 his3
 
D
 
-200 ura3-52 lys2-801 leu2-3,-112
 
This study
TSY681
 
MATa
 
 
 
alf1::URA3 his3
 
D
 
-200 ura3-52 lys2-801 leu2-3,-112
 
This study
TSY828
 
MATa
 
 
 
bik1::ADE2 TUB1:LEU2 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
Botstein lab
TSY979
 
MATa
 
 
 
alf1::URA3 bik1::ADE2 TUB1:LEU2 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
This study
TSY829
 
MATa tub1-836:LEU2 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
Botstein lab
TSY980
 
MATa
 
 
 
alf1::URA3 tub1-836:LEU2 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
This study
TSY830
 
MATa
 
 
 
tub1-831:LEU2 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
Botstein lab
TSY981
 
MATa
 
 
 
alf1::URA3 tub1-831:LEU2 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
This study
TSY831
 
MATa
 
 
 
tub2-442:URA3 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
Huffaker lab
TSY982
 
MATa alf1::HIS3 tub2-442:URA3 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
This study
TSY832
 
MATa tub1-839:LEU2 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
Botstein lab
TSY983
 
MATa alf1::URA3 tub1-839:LEU2 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
This study
TSY833
 
MAT
 
 
 
tub2-408:URA3 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
Huffaker lab
TSY984
 
MATa alf1::HIS3 tub2-408:URA3 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
This study
TSY834
 
MATa tub3::HIS3 TUB1:LEU2 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
Botstein lab
TSY985
 
MATa alf1::URA3 tub3::HIS3 TUB1:LEU2 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
This study
TSY835
 
MATa tub1-801:LEU2 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
Botstein lab
TSY837
 
MATa tub2-428:URA3 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
Huffaker lab
TSY987
 
MATa alf1::HIS3 tub2-428:URA3 his3-
 
D
 
200 ade2-101 leu2-
 
D
 
1 lys2-801 ura3-52
 
This study
TSY839
 
MATa bim1::URA3 ura3-52 leu2-
 
D
 
1 his3-
 
D
 
200
 
Botstein lab
TSY989
 
MATa
 
 
 
alf1::HIS3 bim1::URA3 ura3-52 leu2-
 
D
 
1 his3-
 
D
 
200
 
This study
TSY906
 
MATa cin1::HIS3 his3-
 
D
 
200 lys2-801 leu2-3,-112 ura3-52
 
This lab
TSY990
 
MATa alf1::URA3 cin1::HIS3 his3-
 
D
 
200 lys2-801 leu2-3,-112 ura3-52 This study
TSY907 MATa cin2::LEU2 his3-D200 lys2-801 leu2-3,-112 ura3-52 This lab
TSY991 MATa alf1::URA3 cin2::LEU2 his3-D200 lys2-801 leu2-3,-112 ura3-52 This study
TSY993 MATa cin1::HIS3 cin2::LEU2 his3-D200 lys2-801 leu2-3,-112 ura3-52 This lab
TSY994 MATa alf1::URA3 cin1::HIS3 cin2::LEU2 his3-D200 lys2-801 leu2-3,-112 ura3-52 This study
TSY790 MATa pac2::URA3 his3-D200 lys2-801 leu2-3,-112 ura3-52 This study
TSY789 MATa alf1::HIS3 pac2::URA3 his3-D200 lys2-801 leu2-3,-112 ura3-52 This study
FSY611 MATa rbl2::URA3-hisG ura3-52 leu2-3,-112 lys2-801 his3-D200 Solomon lab
TSY973 MATa alf1::HIS3 rbl2::URA3-hisG ura3-52 leu2-3,-112 lys2-801 his3-D200 This study
TSY908 MATa tub1-1 his3-D200 lys2-801 leu2-3,-112 ura3-52 This lab
Y190 MATa gal4 gal80 his3 trp1-901 ade2-101 ura3-52 leu2-3,-112 URA3::GAL fi lacZ LYS2::GAL fi HIS3 cyl Elledge lab
TSY963 MATa ALF1-myc:URA3 ura3-52 leu2-3,-112 lys2-801 his3-D200 This study
TSY1066 MATa ura3-52 leu2-3,-112 lys2-801 his3-D200 [pTS887] This study
TSY986 MATa alf1-1-myc:URA3 ura3-52 leu2-3,-112 lys2-801 his3-D200 This study
TSY964 MATa cin1::HIS3 ura3-52 leu2-3,-112 lys2-801 his3-D200 [pTS210] This study
TSY965 MATa cin1::HIS3 ura3-52 leu2-3,-112 lys2-801 his3-D200 [pTS863] This study
TSY966 MATa ura3-52 leu2-3,-112 lys2-801 his3-D200 [pTS210] This study
TSY967 MATa ura3-52 leu2-3,-112 lys2-801 his3-D200 [pTS863] This study
TSY968 MATa cin2::LEU2 ura3-52 leu2-3,-112 his3-D200 [pTS210] This study
TSY969 MATa cin2::LEU2 ura3-52 leu2-3,-112 his3-D200 [pTS863] This study
TSY970 MATa cin4::LEU2 ura3-52 leu2-3,-112 lys2-801 his3-D200 [pTS210] This study
TSY971 MATa cin4::LEU2 ura3-52 leu2-3,-112 lys2-801 his3-D200 [pTS863] This study
TSY974 MATa cin1::HIS3 ura3-52 leu2-3,-112 lys2-801 his3-D200 [pTS863, pTS249] This study
TSY975 MATa cin1::HIS3 ura3-52 leu2-3,-112 lys2-801 his3-D200 [pTS336, pTS210] This study
TSY976 MATa cin1::HIS3 ura3-52 leu2-3,-112 lys2-801 his3-D200 [pTS336, pTS863] This study
TSY977 MATa cin1::HIS3 ura3-52 leu2-3,-112 lys2-801 his3-D200 [pTS249, pTS210] This study
TSY972 MATa/a ura3-52/ura3-52 leu2-3,-112/leu2-3,-112 lys2-801/lys2-801 his3-D200/his3-D200 ade2-101/ADE2 [pTS864] This study
TSY995 MATa/a ura3-52/ura3-52 leu2-3,-112/leu2-3,-112 lys2-801/LYS2 his3-D200/his3-D200 ade2-101/ADE2 [pTS864] This study
TSY996 MATa/a ura3-52/ura3-52 leu2-3,-112/leu2-3,-112 lys2-801/LYS2 his3-D200/his3-D200 ade2-101/ADE2 [pTS868] This study
TSY904 MATa tub1-850:LEU2 tub3::HIS3 ura3-52 leu2-3,-112 lys2-801 ade2-101 [pTS864] This study
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creased sensitivity to the anti-microtubule drug benomyl
(Hoyt et al., 1990; Stearns et al., 1990). PAC2, the homo-
logue of cofactor E, was identified as a mutation that is le-
thal in combination with a mutation in CIN8, which en-
codes a kinesin-like protein (Geiser et al., 1997). Although
the mammalian cofactors are required for the in vitro fold-
ing of tubulin, null mutations in each of the yeast genes are
viable. Nonetheless, the mutants all have phenotypes in-
dicative of defects in microtubule function, such as super-
sensitivity to benomyl. Interestingly, the cofactor D homo-
logue in Schizosaccharomyces pombe, alp11, is essential
for viability (Hirata et al., 1998).
Although the mammalian cofactors have been shown to
interact with tubulin, little is known regarding the molecu-
lar nature of that interaction. The only clue from the se-
quence of the cofactors is that both cofactor B/Alf1p and
cofactor E/Pac2p have a single CLIP-170 domain, origi-
nally defined in the microtubule-associated protein CLIP-
170 (Pierre et al., 1992; Hoyt et al., 1997; Tian et al., 1997).
This domain is present in several other microtubule-asso-
ciated proteins including the dynactin subunit p150Glued
and the yeast microtubule-associated protein Bik1p (Pierre
et al., 1992). The relevance of the CLIP-170 domain to co-
factor function has not been established, indeed, CLIP-
170, p150Glued, and Bik1p are thought to interact with mi-
crotubules, rather than monomeric tubulin.
With the hope of understanding the role of the cofactors
in tubulin biogenesis, we have focused on Alf1p/cofactor
B. Cofactor B was identified as a protein that greatly en-
hances the recovery of a- and b-tubulin heterodimer in an
in vitro assembly assay (Tian et al., 1997). Cofactor B in-
teracts with a-tubulin monomer and may serve as a reser-
voir for folding or dimerization intermediates (Tian et al.,
1997). We previously presented an initial characterization
of the yeast homologue of cofactor B, which we named
ALF1 (a-tubulin formation 1; Tian et al., 1997). An alf1
null mutation is viable but results in supersensitivity to
benomyl and lethality in combination with the a-tubulin
allele, tub1-1, consistent with ALF1 being involved in mi-
crotubule function. The results here indicate that Alf1p is
an a-tubulin monomer-binding protein. Residues involved
in the Alf1p—a-tubulin interaction were mapped onto the
structure of a-tubulin, defining a binding site for Alf1p.
This interaction depends upon the CLIP-170 domain in
Alf1p, suggesting that the CLIP-170 domain may specifi-
cally recognize a-tubulin.
Materials and Methods
Yeast Strains, Media, and Plasmids
The yeast strains used in this study are listed in Table I. Bacterial strains
and plasmids are listed in Table II. Yeast extract/peptone (YEP)1, syn-
thetic dextrose (SD) and sporulation media were as described (Adams et al.,
1997). Strains requiring expression of a plasmid-borne PGAL1-ALF or
-TUB3 construct were grown on minimal media 1 2% galactose. Yeast
molecular genetic methods were as described (Adams et al., 1997).
Benomyl, 98.6% pure, was a generous gift from E.I. duPont de Nemours
and Co., Inc., and was kept in a 10 mg/ml stock in DMSO at 2208C.
Benomyl was added to media in final concentrations of 1, 2, 5, 10, 15, 20,
30, 50, and 80 mg/ml. Growth of strains on solid media was assayed by sus-
pending cells in sterile water and spotting onto plates using a multi-
pronged inoculating device.
Fluorescence and Immunological Techniques
Immunofluorescence was performed as described (Pringle et al., 1989)
with the following changes. To visualize microtubules, cells were fixed by
adding formaldehyde to a final concentration of 3.7% and incubating at
room temperature for 2 h, followed by methanol/acetone treatment. Pri-
mary antibody YOL1/34 (Kilmartin et al., 1982) was detected with Texas
red—conjugated donkey anti—rat antibodies (Jackson ImmunoResearch
Laboratories, Inc.).
Green fluorescent protein (GFP) fluorescence was visualized in living
cells using a fluorescein filter set (Hi-Q FITC; Chroma Technology Corp.)
on a microscope (Axioskop; Carl Zeiss, Inc.) equipped with an HBO100
mercury lamp and 3100/1.3 objective lens. To visualize GFP in living
cells, strains containing GFP plasmids under the control of the GAL1 pro-
moter were grown overnight at 308C in minimal media containing 2% ga-
lactose 1 0.5% glucose; the addition of glucose reduces the expression
from the GAL1 promoter, thus reducing background fluorescence (Mar-
schall et al., 1996).
ALF1 Plasmid Constructs
To construct a PGAL1 -ALF1 plasmid, the ALF1 gene was generated by
PCR with BamHI and XbaI ends using the following primers: YNL148.5
59-GGCGGATTCCATAAATGGTTAGAGTTGTCA-39 and YNL148.7
59-GCCTCTAGATCAAATTTCATCATCGCTCTC-39.
All PCR reactions used Vent polymerase (New England Biolabs) to
amplify directly from genomic DNA unless otherwise specified. The re-
sultant PCR product was cleaved with BamHI and XbaI and cloned into
the same sites in pTS210, a centromere based PGAL1 vector with the ACT1
transcriptional terminator.
To construct an Alf1p-GFP fusion protein, a version of the ALF1 gene
with BamHI and XbaI ends was generated by PCR using the following
primers: YNL148.5 (described above) and YNL148.6 59-GGCTCTA-
GAAATTTCATCATCGCTCTCCAC-39. The resulting PCR product
was cleaved with BamHI and XbaI and cloned into pTS586, a centromere
1. Abbreviations used in this paper: c-cpn, cytosolic chaperonin; GFP,
green fluorescent protein; SD, synthetic dextrose; YEP, yeast extract/pep-
tone; SD, synthetic dextrose.
Table II. Plasmid List
Plasmid Relevant Markers Source
pTS210 PGAL1; URA3, YCp This lab
pTS249 PGAL1; LEU2, YCp This lab
pAS1 PADH; GAL4 DNA-binding domain TRP1; YEp Elledge lab
pACTII PADH; GAL4 activation domain LEU2; YEp Elledge lab
pDAb1 PADH; GAL4 DNA-binding domain TRP1; YCp Botstein lab
pTS869 CIN1-pAS1 This study
pTS870 CIN1-pACTII This study
pTS862 PAC2-pACTII This study
pTS860 ALF1-pAS1 This study
pTS861 ALF1-pACTII This study
pTS863 PGAL1-ALF1, URA3, YCp This study
pTS887 PGAL1-ALF1-myc, URA3, YCp This study
pTS864 PGAL1-ALF1-GFP, URA3, YCp This study
pTS865 ALF1-myc, URA3, YIp This study
pTS866 alf1-1-pAS1 This study
pTS867 alf1-1-pACTII This study
pTS868 alf1-1-GFP, URA3, YCp This study
pTS889 alf1-1-myc, LEU2, YIp This study
pTS336 PGAL1-TUB3, LEU2, YCp This study
pTS871 TUB1, pACTII* This study
pTS872 CCT5-pACTII* This study
pRB2514 TUB1-pAS1 Botstein lab
pRB2516 TUB1-pACTII Botstein lab
*Plasmids were isolated from a two-hybrid screen with Alf1p.
àIndicates that the TUB2 allele used in the two-hybrid assay is not wild-type (see Re-
sults for description).
⁄Indicates that the CIN2 allele used in the two-hybrid assay is not full-length (see Ma-
terials and Methods for more details).
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based PGAL1-GFP vector with the ACT1 transcriptional terminator, con-
taining the GFP mutant, GFPMUT3 (Cormack et al., 1996), creating the
PGAL1-ALF1-GFP construct, pTS864. pTS864 was transformed into a
wild-type diploid yeast strain to create TSY972.
Integrated myc-tagged ALF1 was created by cloning the ALF1
BamHI-XbaI fragment from pTS864 into pTS776, an integrating vector
with the URA3 marker, to generate pTS865. pTS865 was cut with EcoRI,
which cuts in the ALF1 gene, and transformed into a wild-type haploid
strain (DBY4974) to create TSY963. PGAL1-ALF1-myc was constructed
by PCR using the YNL148.5.6 primers (described above). The ALF1 gene
was cloned into pTS466, a CEN-based vector with the GAL1 promoter
and a 39 myc tag, creating pTS887. pTS887 was transformed into a haploid
yeast strain, creating TSY1066; Alf1p-myc was induced by growing in se-
lective medium containing either 2% galactose, or 2% galactose and 0.5%
glucose.
The Alf1p two-hybrid bait plasmid was constructed as follows. The
ALF1 gene was generated by PCR with NcoI and BamHI ends using
the following primers: YNL148.13 59-GCCCCATGGTTAGAGTTGT-
CATA-39 and YNL148.14 59-GCCGGATCCAATTTATCATCGCTT-
CTC-39. The resulting PCR product was digested with NcoI and BamHI
and cloned into pAS1-CYH2 to create pTS860 (Durfee et al., 1993). This
plasmid was transformed into the two-hybrid strain Y190 and tested for
expression of the fusion protein by Western analysis. The resulting strain
was named TSY1013.
Two-Hybrid Analyses
The two hybrid system used was that described in Durfee et al. (1993). In
this system, both HIS3 and lacZ are used as reporters of interaction. The
lYES cDNA library was titered and amplified in bacterial strain LE392
(Elledge et al., 1991). Plasmid inserts were excised from the lYES cDNA
library by infection of strain BNN132 (Elledge et al., 1991). TSY1013 was
transformed with library DNA by a lithium acetate protocol (Adams et
al., 1997) and plated on SD 1 10 mg/ml adenine 1 25 mM 3-aminotri-
azole. The plates were incubated at 308C for 9 d. Approximately 9 3 106
transformants were screened in this manner.
As a secondary test, His1 strains were assayed for b-galactosidase ac-
tivity. Strains were patched onto SC-trp-leu media, grown overnight, lifted
on nitrocellulose filters (BA85; Schleicher and Schuell, Keene, NH) and
immersed in liquid nitrogen for 10 s. The filters were then placed on
Whatman paper soaked with 3 ml of Z buffer (60 mM Na2HPO4, 40 mM
NaH2P04, 10 mM KCl, 1 mM MgSO4, and 50 mM b-mercaptoethanol, pH
7.0) containing 0.05% X-Gal. Filters were incubated at 308C for 6 h and
scored for the development of blue color. Clones that passed the second-
ary test were tested for solo activation by growth on SC-leu media with 5
mg/ml cycloheximide. The strains were confirmed to have lost the TRP1-
containing bait plasmid by failure to grow on SC-trp media. Library in-
serts were sequenced on one strand with a Thermo Sequenase dye termi-
nator cycle sequencing kit (Amersham Life Science) with primer 2-H1
(TGATGAAGATACCCCACC) and identified by a BLAST search
(Altschul et al., 1990) via the Saccharomyces Genome Database (http://
genome-www.stanford.edu).
Yeast Protein Extract Preparation
Protein extracts for Western analysis were prepared by disrupting yeast
cells with glass beads as described (Kaiser et al., 1987). Protein extracts for
immunoprecipitations were made in the following manner. Yeast were
grown in 20 ml of YPD overnight to late log phase, harvested, and
washed. Cells were resuspended in 5 ml 20 mM Tris, pH 7.8, 0.1 M b-mer-
captoethanol and 1 M sorbitol at 308C for 10 min. Cells were centrifuged
and resuspended in 5 ml 1 M sorbitol, 10 mM potassium phosphate solu-
tion, pH 6.0, in the presence of protease inhibitors (100 mg/ml PMSF, and
5 mg/ml each of pepstatin, leupeptin, and chemostatin) and 100 mg/ml zy-
molyase, followed by incubation at 308C for 20—30 min. The resulting
spheroplasts were centrifuged and resuspended in 200 ml HBS (50 mM
Hepes, 150 mM NaCl, pH 7.4, and 0.5% Triton X-100) in the presence of
protease inhibitors, and transferred to a 15-mm test tube. Acid-washed
glass beads were added to the liquid meniscus and tubes were vortexed
twice for 40 s each time. Extract was removed from the beads and centri-
fuged at 48C for 10 min at 10,000 g. Bradford assays (Bio-Rad) were per-
formed on the cleared extract.
Immunoprecipitations
Cell extracts were prepared as described above. Equal amounts of protein
were added to two Eppendorf tubes, each containing protein A—Seph-
arose (Sigma Chemical Co.) and the monoclonal anti-myc antibody 9E10.
In one tube a 10-fold molar excess of competing antigenic peptide was
added. Immunoprecipitations were performed at 48C for 1 h on a rotator.
The immunoprecipitates were washed twice in lysis buffer, twice in 50 mM
Hepes, 250 mM NaCl, pH 7.4, and 0.5% Triton X-100, and once again in
lysis buffer. 60 ml of sample buffer was added to each tube and incubated
for 5 min at room temperature, and 20 ml was used per lane on a protein
gel. Incubation at room temperature was found to dissociate the antibod-
ies from protein A but not to dissociate the two heavy chains of the anti-
body, resulting in the heavy chains migrating at a molecular weight that
does not interfere with the migration and visualization of tubulin (Murphy
et al., 1998).
Immunoblotting
Protein samples were separated on 10% SDS—polyacrylamide gels, elec-
trophoretically transferred to nitrocellulose, and then blocked overnight
in 4% nonfat dried milk in TBST (10 mM Tris, pH 8.0, 150 mM NaCl,
0.05% IGEPAL). The following primary antibodies were used for this
study: 206, rabbit anti-b-tubulin (F. Solomon, MIT, Cambridge, MA);
TAT-1, mouse anti-a-tubulin (K. Gull, University of Manchester, Man-
chester, England); 345, rabbit anti-a-tubulin (D. Botstein, Stanford Uni-
versity, Stanford, CA); and guinea pig anti-actin (D. Botstein). Primary
antibody incubations were followed by incubation with HRP-conjugated
anti—mouse, anti—rabbit, or anti—protein A antibodies (Jackson Immuno-
Research Laboratories, Inc.). Immunoreactive proteins were visualized by
chemiluminescence (Amersham Pharmacia Biotech Inc.).
Construction of the ALF1 CLIP-170 Mutant
The conserved CLIP-170 motif GKNDG of Alf1p was mutated to
AENDA as follows. Complementary oligonucleotides were designed to
introduce into ALF1 both the desired amino acid changes and a PvuII site
for diagnostic purposes:
ALF1.8 59-AATTCCCGGAAGCCGCAGCTGAAAACGATGCTC-
GCATAAATGGGGTAACACTGTTTGGGCCTGTGG-39 and ALF1.9
59-CGCCACAGGCCCAAACAGTGTTACCCCATTTATGCGAGCA-
TCGTTTTCAGCTGCTGCGGCTTCCGGG-39. When hybridized, the
ends of the resulting duplex form NarI and EcoRI overhangs for cloning.
The oligos were hybridized and the ends were kinased with T4 polynucle-
otide kinase (New England Biolabs). pTS826, containing wild-type ALF1
under its own promoter, was cut with EcoRI and religated to make
pBF87, deleting a 0.7-kb piece of ALF1. pBF87 was cut with EcoRI and
NarI and ligated to ALF1.8.9 plus the 0.7-kb piece removed in the previ-
ous step, thereby replacing the wild-type CLIP-170 domain in ALF1, re-
sulting in pTS878.
The mutant, alf1-1, was cloned into two-hybrid vectors by PCR using
YNL148.13 and YNL148.14 primers and Vent polymerase, and the se-
quence of the resulting plasmid, pTS866 was confirmed by sequencing.
This plasmid was transformed into the two-hybrid strain Y190 and tested
for expression of the fusion protein by Western analysis.
Integrated myc-tagged alf1-1 was created in the following manner. alf1-1
was cloned by PCR into pTS776, an integrating vector with a 39 myc-tag
and a URA3 marker, to generate pTS886. alf1-1-myc was removed from
pTS886 by digestion with BamHI and SalI, and subcloned into pRS305, a
LEU2-based integration vector, creating pTS889. pTS889 was cut with
MscI, which cuts 59 to the mutation in alf1-1, and transformed into a wild-
type haploid strain (DBY4974) to create TSY986.
Tubulin Mapping
A panel of alanine scan tub1 mutants generated by K. Richards (Richards,
1997) was cloned into pAS1 (Schwartz et al., 1997). Two PCR isolates of
each tub1 mutant were transformed separately into Y190, containing
Alf1p-pACTII, and tested for their ability to activate the reporter gene
lacZ, in the X-gal filter lift assay. The Alf1p constructs and assay are de-
scribed above.
The tub1 mutants that did not interact with Alf1p were mapped onto
the predicted structure of yeast a-tubulin, as determined by homology
modeling using the mammalian a-tubulin structure. Modeling was done
on a Silicon Graphics Indigo workstation (Silicon Graphics), using Look
3.0 software (Molecular Applications Group).
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Results
Alf1p Physically Interacts with a-Tubulin
Cofactor B was identified on the basis of its interaction
with a-tubulin, and its ability to assist in the formation of
the tubulin heterodimer. This role predicts a direct inter-
action with a-tubulin, and possibly with other members of
the same pathway. To identify such interacting proteins we
performed a yeast two-hybrid screen with the yeast cofac-
tor B ortholog Alf1p. ALF1 was fused to the GAL4 DNA-
binding domain and the construct was shown to express the
expected 40-kD fusion protein. A library of yeast cDNAs
fused to the GAL4 activation domain was screened for in-
teraction with Alf1p. Among the positive clones, TUB1
and TUB3, the major and minor a-tubulin genes, and
CCT5, a subunit of the Cct/TRiC complex, were repre-
sented by several independent clones (Fig. 1 A). The a-tubu-
lin isolates were full-length clones, whereas the CCT5 iso-
lates were not full-length, but each contained at least the
last 600 bp of the ORF. Alf1p was also found to interact
with TUB1 when tested directly in the two-hybrid assay
(Table III).
We were interested to know whether Alf1p interacted
with Pac2p, since their mammalian counterparts both in-
teract with a-tubulin, and are thought to act sequentially
(Tian et al., 1996). Alf1p and Pac2p failed to interact with
each other in the assay, but Pac2p did interact with a-tubu-
lin (Table III), consistent with the biochemical results
(Tian et al., 1996). Alf1p was also tested for interactions
with Cin1p and itself, with negative results (Table III).
Interaction between Alf1p, or the other cofactors, and
b-tubulin could not be tested directly because overexpres-
sion of either the b-tubulin gene, TUB2, or the required
two-hybrid fusion is lethal in yeast.
To determine whether the interaction of Alf1p with
a-tubulin observed in the two-hybrid assay reflects a genu-
ine in vivo association, we immunoprecipitated Alf1p and
tested for the presence of a-tubulin in the precipitate. A
single myc-tag was integrated at the 39 end of the genomic
copy of ALF1 in a haploid strain. This strain was pheno-
typically wild-type, indicating that the tag did not interfere
with Alf1p function. Western blots of anti-myc immuno-
precipitates from this strain were tested for the presence
of Alf1p, a-tubulin, and b-tubulin. a-Tubulin coimmuno-
precipitated with the epitope-tagged Alf1p but b-tubulin
did not (Fig. 1 B). Under the conditions used, the sensitiv-
ity of detection of the anti-a-tubulin and anti-b-tubulin an-
tibodies was comparable. These results indicate that Alf1p
physically interacts with a-tubulin but not b-tubulin. In ad-
dition, this interaction appears to be specifically with the
a-tubulin monomer rather than the tubulin heterodimer,
because b-tubulin did not coimmunoprecipitate with the
Alf1p—a-tubulin complex.
If Alf1p were involved with the folding or biogenesis of
a-tubulin, we reasoned that alf1D strains might show re-
duced amounts of a-tubulin, due to the degradation of
unfolded intermediates. This would, in part, explain the
benomyl sensitivity of alf1 null strains, because strains
with reduced amounts of a-tubulin (i.e., tub3D strains) are
benomyl sensitive (Schatz et al., 1986). Extracts from alf1D
and wild-type cells were tested by Western blotting and
were found to have approximately the same amounts of
both a- and b-tubulin (Fig. 2).
Interaction of Alf1p with a a-Tubulin requires the Alf1p 
CLIP-170 Domain
Alf1p and cofactor B contain one copy of the CLIP-170
microtubule-binding domain found in the mammalian
CLIP-170 protein, the p150Glued subunit of dynactin, and
yeast BIK1 (Pierre et al., 1992; Fig. 3 A). This domain is
also found in cofactor E and its yeast ortholog Pac2p
(Hoyt et al., 1997; Tian et al., 1997; Fig. 3 A). CLIP-170
and Bik1p have been shown to localize to microtubules in
vivo (Berlin et al., 1990; Pierre et al., 1992). We wished to
test whether the CLIP-170 domain was important for
Alf1p interaction with a-tubulin, as well as for Alf1p func-
tion in general. This was tested by creating a mutant allele,
alf1-1, in which the conserved CLIP-170 domain sequence
GKNDG was changed to AENDA (Fig. 3 A); the same
Figure 1. Alf1p interactions.
(A) TUB1 and CCT5 are iso-
lated in a two-hybrid screen
with Alf1p. The strains tested
are indicated at the left of the
figure; the gene on top was
cloned into the plasmid
pAS1, and the gene on the
bottom was cloned into the
plasmid pACTII. All strains
can grow on permissive me-
dium (1his). Only strains
carrying ALF1 as well as
TUB1 or CCT5, but not vec-
tor alone, can grow on restrictive medium (2his 13-AT). (B)
Alf1p coimmunoprecipitates with a-tubulin, but not b-tubulin.
Alf1p-myc was immunoprecipitated from extracts with anti-myc
mAb in the absence (myc) or presence (myc 1 peptide) of com-
peting antigenic peptide. Precipitates were immunoblotted with
either anti-myc, anti-a-tubulin, or anti-b-tubulin antibodies, as
indicated on the left-hand side of the figure.
Table III. Summary of Two-Hybrid Interactions
DNA-binding domain
fusion (pAS1)
Activation domain
fusion (pACTII) Interaction
ALF1 TUB1 1
ALF1 ALF1 2
ALF1 CIN1 2
ALF1 PAC2 2
TUB1 PAC2 1
CIN1 PAC2 2
CIN1 TUB1 2
Constructs were tested in the Y190 strain for their ability to activate the lacZ reporter
gene in a colormetric assay (see Materials and Methods).
The Journal of Cell Biology, Volume 144, 1999 118
mutation was made previously in CLIP-170 and found to
abolish microtubule binding (Pierre et al., 1994).
alf1-1 was cloned into vectors to test complementation
of the alf1 null phenotype, and for the ability to interact
with a-tubulin. Expressed at endogenous levels, alf1-1 did
not complement the benomyl sensitivity of an alf1 null
mutant. In the two-hybrid assay alf1-1 was unable to inter-
act with TUB1; this result was obtained with alf1-1 as ei-
ther bait or prey in the assay (Fig. 3 B). Consistent with
the two-hybrid data, an epitope-tagged version of alf1-1p,
alf1-1p-myc was unable to coimmunoprecipitate a-tubulin
(Fig. 3 C). Although the alf1-1 mutant did not complement
an alf1 null and did not interact with a-tubulin, it was ex-
pressed at a level similar to that of ALF1 (not shown),
could be immunoprecipitated (Fig. 3 C), and was able to
interact with CCT5 in the two-hybrid assay (not shown).
These results suggest both that the interaction of Alf1p
with a-tubulin depends on the CLIP-170 domain, and that
the loss of this activity results in the benomyl supersensi-
tivity in the alf1 null mutant.
Mapping the Alf1p Binding Site on a-Tubulin
The above experiments demonstrate that the CLIP-170
domain is necessary for Alf1p interaction with a-tubulin.
Next we determined the residues of a-tubulin involved in
interaction with Alf1p, taking advantage of a panel of
a-tubulin alanine-scan mutants (Richards, 1997; Schwartz
et al., 1997). In this set of mutants, clusters of charged resi-
dues in TUB1 were changed to alanines, with the rationale
that such residues are likely to be on the surface of the
molecule, and potentially involved in interaction with other
proteins (Cunningham and Wells, 1989).
We used the two-hybrid system to assess the ability of
these a-tubulin mutants to interact with Alf1p, as de-
scribed previously for other a-tubulin ligands (Schwartz
et al., 1997). 53 of the tub1 mutant alleles were fused to the
GAL4 DNA-binding domain and tested for their ability to
interact with Alf1p. Each combination was tested for its
ability to activate the lacZ reporter gene (Table IV). By
this assay, most of the a-tubulin mutants could still in-
teract with Alf1p, however the following alleles failed to
interact: tub1-814 (R106A, H108A), tub1-819 (T146A),
tub1-822 (K167A, E169A), tub1-823 (E197A, H198A,
D200A), tub1-824 (D206A,E208A), tub1-829 (R265A,
H267A), tub1-834 (R321A, D323A), tub1-840 (D393A,
R394A, K395A, D397A), tub1-842 (K395A, D397A),
tub1-843 (K395A), tub1-844 (D397A), tub1-845 (K402A,
R403A), and tub1-847 (E416A, E418A), tub1-848 (E421A,
R423A, E424A, D425A), tub1-849 (E430A, R431A,
D432A), tub1-850 (E435A, D439A), tub1-851 (E443A,
E444A, E445A, E446A), tub1-852 (F447A), and tub1-853
(E183A). In addition, the following alleles displayed posi-
tive, but weak, interaction: tub1-818 (D128A, D131A),
tub1-821 (E161A, K164A, K165A), tub1-830 (K279A,
K281A), and tub1-838 (D373A, R374A).
Figure 2. alf1D cells have normal levels of a- and b-tubulin. Cy-
toplasmic extracts were prepared from ALF1 and alf1D cells and
immunoblotted with anti-a-tubulin, anti-b-tubulin, and anti-actin
antibodies. Actin was used as a control for loading. The amounts
of a- and b-tubulin were quantitated by densitometry.
Figure 3. The CLIP-170 do-
main of Alf1p is required for
the interaction with a-tubu-
lin. (A) Alf1p contains a
CLIP-170 microtubule-bind-
ing domain. The CLIP-170
domains of the yeast pro-
teins, Alf1p, Pac2p, and
Bik1p, and the mammalian
proteins, CLIP-170, cofactor
B, cofactor E and p150Glued
are aligned. Shaded regions
indicate residues identical or
similar to Alf1p. Site-directed mutations were constructed in the
CLIP-170 domain of Alf1p, creating alf1-1. Arrows indicate the
amino acids changed. (B) alf1-1 does not interact with a-tubulin
in the two-hybrid assay. The strains tested are indicated at the
left of the figure; the gene on top was cloned into the plasmid
pAS1, and the gene on the bottom was cloned into the plasmid
pACTII. All strains grow on permissive medium (1his). Strains
bearing both ALF1 and TUB1 plasmids are able to grow on the
restrictive condition (2his 1 3-AT), whereas those bearing alf1-1
and TUB1 are not, indicating that alf1-1p does not interact with
Tub1p as either bait or prey. (C) alf1-1p-myc does not coimmu-
noprecipitate with a-tubulin. alf1-1p-myc was immunoprecipi-
tated from extracts with anti-myc mAb in the absence (myc) or
presence (myc 1 peptide) of competing antigenic peptide. Pre-
cipitates were immunoblotted with either anti-myc, anti-a-tubu-
lin, or anti-b-tubulin antibodies, as indicated on the left-hand
side of the figure.
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To determine whether these differential interactions de-
fine a specific domain on the surface of a-tubulin, we
mapped the mutations onto the structure of yeast Tub1p.
Fig. 4 A shows the putative space-filling structure of yeast
a-tubulin, modeled on the mammalian a-tubulin structure,
and oriented with the GTP-binding site at the top of the
figure (Nogales et al., 1998). Residues that either do not
interfere with Alf1p binding when mutated or were not
mutated are displayed in gray. The residues that abolish
Alf1p interaction when mutated are displayed in yellow.
Interestingly, these residues are clustered together on the
outside face of a-tubulin. Note that gray residues within
the yellow patches might be involved in interaction with
Alf1p, but were not mutagenized because they are not part
of charged clusters. The tub1-814, tub1-823, tub1-834, and
tub1-845 alleles do not interact with Alf1p, but are not
shown as yellow in the figure, because they do not interact
with several other known a-tubulin interacting proteins in
the two-hybrid assay, such as Bim1p and Bik1p (Schwartz
et al., 1997). Most of these alleles map to regions buried
within the a-tubulin structure, suggesting that the muta-
tions might affect Alf1p binding in a nonspecific manner.
The tub1-850, tub1-851, tub1-852, and tub1-853 alleles
were also not included in the figure because they map to
the a-tubulin COOH terminus, which is not resolved in
the existing structure (Nogales et al., 1998). The interac-
tions shown in Fig. 4 A were also mapped onto the a-tubu-
lin a-carbon backbone, shown in stereo view in Fig. 4 B.
Alf1p Localization to Microtubules In Vivo Depends on 
Its CLIP-170 Domain
We have shown that Alf1p binds to a-tubulin monomer
and that the CLIP-170 domain is required for this interac-
tion. Yet, the CLIP-170 domain was originally identified in
proteins that associate with microtubule polymer. To de-
termine whether Alf1p associates with microtubule poly-
mer in vivo, an ALF1-GFP fusion was constructed. When
expressed at endogenous levels, no specific localization
of Alf1p-GFP was apparent. To increase the amount of
Alf1p-GFP in the cell, the fusion protein was placed under
the control of the GAL1 promoter. Under conditions of
full induction, which resulted in 200-fold overexpression
relative to wild-type Alf1p, Alf1p-GFP was present through-
out the cytoplasm (not shown). However, when the level
of expression from the GAL1 promoter was reduced to
only several-fold above that of wild-type Alf1p, the fusion
protein localized to both nuclear and cytoplasmic microtu-
bules throughout the cell cycle (Fig. 5 A). The Alf1p-GFP
fluorescence was brighter on the spindle than on cytoplas-
mic microtubules, consistent with the greater number of
spindle microtubules relative to cytoplasmic microtubules
(Byers and Goetsch, 1975; Winey et al., 1995). To deter-
mine whether localization of Alf1p-GFP to microtubules
was dependent on the CLIP-170 domain, an alf1-1p-GFP
fusion was created. When expressed under the same con-
ditions of induction as in Fig. 5 A, alf1-1p-GFP did not lo-
calize to microtubules (Fig. 5 B). Taken together, these re-
sults suggest that Alf1p can localize to the microtubule
cytoskeleton, and that this localization is dependent upon
its CLIP-170 domain.
The Alf1p binding site on a-tubulin defined in the two-
hybrid study above includes much of the cytoplasmic face
of a-tubulin, as it is oriented in the microtubule. We
wished to test whether Alf1p associated with microtubule
polymer using this same binding site. Alf1p-GFP was
tested for localization to microtubules in two of the tub1
mutants that failed to interact with Alf1p in the two-hybrid
assay, but which have a morphologically normal microtu-
bule cytoskeleton. When Alf1p-GFP was expressed in ei-
ther tub1-850 or tub1-852 strains, Alf1p-GFP did not local-
ize to microtubules (tub1-850 shown in Fig. 5 C). This
result suggests that Alf1p interacts with the a-tubulin
monomer and the microtubule polymer via the same site
on a-tubulin.
Phenotypes of ALF1 Overexpression
The association of Alf1p with a-tubulin monomer raises
the possibility that Alf1p can act to sequester a-tubulin
from interaction with b-tubulin. If this were the case, then
overexpression of Alf1p might result in an imbalance in
the ratio of a-tubulin to b-tubulin, which is detrimental to
microtubule function in yeast (Burke et al., 1989; Katz et al.,
1990; Weinstein and Solomon, 1990). To determine the ef-
fect of increased Alf1p levels, ALF1 was placed under the
control of the inducible GAL1 promoter. Induction of
PGAL1-ALF1 in wild-type cells had no effect on growth
(Fig. 6 A). We next tested the phenotype of Alf1p overex-
pression in cin1 and rbl2 mutants, which function in the
production of b-tubulin, with the rationale that compro-
mising their function would exacerbate any effect of Alf1p
overexpression. Induction of PGAL1-ALF1 in a rbl2 mutant
strain caused a slight reduction growth rate (not shown),
whereas induction in a cin1 mutant strain resulted in le-
thality (Fig. 6 A). This effect appears to be dependent
upon the ability of Alf1p to interact with a-tubulin, since
Table IV. Two-Hybrid Interaction of Alf1p with tub1 Mutants
tub1 allele
Interacts
in Assay tub1 allele
Interacts
in Assay tub1 allele
Interacts
in Assay
tub12801 1 2820 d.l. 2837 1
2802 1 2821 1à 2838 1
2803 1 2822 2 2839 1
2804 1 2823* 2 2840 2
2805 1 2824 2 2841 1
2808 1 2825 1 2842 2
2809 1 2826 1 2843 2
2810 1 2827 1 2844 2
2811 1 2828 d.l. 2845* 2
2812 1 2829 2 2846 1
2813 1 2830 1à 2847 2
2814* 2 2831 1 2848 2
2815 1 2832 1 2849 2
2816 1 2833 1 2850 2
2817 1 2834* 2 2851 2
2818 1à 2835 1 2852 2
2819 2 2836 1 2853 2
Strains bearing both ALF1 and TUB1 (allele indicated) plasmids were patched onto
selective media and after 1 d of growth were assayed for lacZ expression. "1" indi-
cates that the tub1 allele tested positive in the assay with ALF1, and "2" indicates a
negative result. *d.l., Dominant lethal allele.
*Alleles of tub1 that do not interact with any known tubulin-binding proteins, sug-
gesting that the negative result may not be specific to Alf1p.
àIndicates a very weak positive interaction.
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overexpression of alf1-1p is viable in a cin1D strain (not
shown). If the lethality of overexpression of Alf1p were
due to sequestration of a-tubulin, then it should be possi-
ble to overcome it by overexpressing a-tubulin with Alf1p.
Consistent with this hypothesis, a cin1 strain expressing
both PGAL1-TUB3 and PGAL1-ALF1 was viable (Fig. 6 A).
We note that overexpression of Alf1p also results in asso-
ciation of Alf1p with tubulin heterodimer (see below),
thus it is possible that the observed lethality is due to se-
questration of the tubulin heterodimer rather than the
a-tubulin monomer.
ALF1 overexpression in cin1 cells caused a cell cycle ar-
rest consistent with a defect in microtubule function. After
12 h of ALF1 induction, 75% of the cin1 cells had large
buds, whereas cin1 cells with a control plasmid had a bud
size distribution typical of exponentially growing cells (not
shown). Large-budded arrest is typical of, but not specific
to, defects in the microtubule cytoskeleton. To determine
directly if ALF1 overexpression had an effect on the mi-
crotubule cytoskeleton in cin1 cells, microtubules were
visualized by immunofluorescence at time points after
ALF1 induction. After 9 h of ALF1 induction, virtually all
of the cells lacked microtubule structures, although some
retained dots of staining adjacent to the nucleus, presum-
ably representing the spindle pole bodies (Fig. 6 B). In
contrast, z95% of the cin1 cells bearing the control vector
plasmid contained microtubules observable by immuno-
fluorescence.
The amount of a-tubulin associated with Alf1p under
overexpression conditions was determined by immunopre-
cipitation. A myc-tagged version of ALF1 was placed un-
der control of the GAL1 promoter on a CEN-based plas-
mid. This protein was overexpressed in alf1 null cells and
immunoprecipitated with the anti-myc antibody. a-Tubu-
lin coimmunoprecipitated with Alf1p-myc, as expected.
Although the total amount of a-tubulin in these cells was
approximately the same as in wild-type cells, the amount
of a-tubulin associated with the overexpressed Alf1p-myc
was 12-fold greater than found with endogenous levels of
Alf1p-myc (Fig. 7). In addition, b-tubulin coimmunopre-
cipitated with Alf1p-myc. This is most likely due to associ-
ation of Alf1p-myc with the tubulin heterodimer, although
we cannot rule out the possibility that high levels of Alf1p
result in association with b-tubulin monomer, or in associ-
Figure 4. Alf1p binding site on a-tubu-
lin. The structure of the yeast TUB1
a-tubulin was determined by homol-
ogy modeling using the mammalian
a-tubulin structure (Richards, 1997).
Both views of the a-tubulin structure
are shown in the same orientation,
with the GTP-binding site at the top.
(A) Space-filling model of a-tubulin.
The residues that disrupt the interac-
tion with Alf1p when mutated are in-
dicated in yellow. (B) Stereo view of
the a-tubulin a-carbon backbone
(magenta) in the context of a pro-
tofilament. The protofilament runs
vertically and the surface facing the
viewer corresponds to the outside of
the microtubule. The residues that
disrupt the interaction with Alf1p
when mutated are indicated in yel-
low. Several of the helices in a-tubu-
lin, as described in Nogales et al.
(1998) are indicated for reference. A
dimer is formed with the partial
b-subunit at the top (violet), while
the partial b-tubulin at the bottom
(aquamarine) corresponds to another
dimer.
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ation with a complex containing the tubulins and other co-
factors. The amount of b-tubulin that coimmunoprecipi-
tated with Alf1p-myc was strictly dependent on the amount
of overexpression. At the full level of induction (z200-
fold over wild-type), approximately twice as much a-tubu-
lin than b-tubulin was precipitated, whereas at the reduced
level of induction used in the localization experiments
above, z20 times more a-tubulin than b-tubulin was pre-
cipitated (not shown). We interpret these results to mean
that Alf1p preferentially binds to a-tubulin monomer, thus
under conditions of overexpression, Alf1p will associate
with the available a-tubulin monomer first, then with tu-
bulin heterodimer as the amount of Alf1p increases.
Genetic Interactions of alf1D with Tubulin and 
Cofactor Mutants
It was shown previously that alf1 null mutants are lethal in
combination with tub1-1, a mutation in the major yeast
a-tubulin gene (Stearns and Botstein, 1988; Tian et al.,
1997). To further characterize alf1-tubulin genetic interac-
tions, alf1 null strains were crossed to a set of tubulin mu-
tants with a range of phenotypic defects. Among a-tubulin
alleles, combination with alf1 null resulted in either lethal-
ity or increased sensitivity to benomyl in comparison to ei-
ther of the parental single mutants (Table V). Most alf1D
tub1 double mutants also exhibited increased sensitivity to
cold (not shown), which, like benomyl sensitivity, is gen-
erally indicative of compromised microtubule function.
Among b-tubulin alleles, combination with alf1 null re-
sulted in increased sensitivity to benomyl with two of three
tested alleles (Table V). An interesting exception to the
above was the alf1D tub2-428 double mutant that was
more resistant to benomyl than either parental single mu-
tant. If Alf1p was required to fold, or otherwise aid in the
biosynthesis, of a-tubulin, then this suppression of tub2-
428 might be mimicked by a reduction in a-tubulin levels.
One way of reducing a-tubulin levels is to delete the minor
a-tubulin gene, TUB3 (Schatz et al., 1986). However, com-
bination of tub3D with tub2-428 resulted in lethality rather
than suppression (not shown).
The alf1 null mutant was also tested for genetic interac-
tions with the other yeast cofactor genes. As with the tubu-
lin mutants, most of the double mutants were more sensi-
tive to benomyl than either of the parental single mutants
(Table V). An exception was the alf1D pac2D double mu-
tant, which exhibited the same sensitivity to benomyl as
the pac2D single mutant. This result is consistent with the
biochemical determination that cofactor B/Alf1p and co-
factor E/Pac2p act in the same pathway (Tian et al., 1997).
To see whether the b-tubulin cofactors displayed a similar
epistasis relationship, we crossed cin1 and rbl2 mutant
strains. The putative double mutants from this cross were
inviable; occasional spore microcolonies that did appear
could not be propagated.
Discussion
Formation of the a- and b-tubulin heterodimer requires
the action of several proteins and protein complexes in
vitro. We have tested the in vivo function of one of these
proteins, Alf1p, the yeast ortholog of cofactor B. Alf1p
binds to a-tubulin, and can localize to microtubules in
vivo. The interaction with a-tubulin monomer and micro-
tubules is dependent upon both the single CLIP-170 mi-
crotubule-binding domain of Alf1p and a specific domain
of a-tubulin. ALF1 displays genetic interactions with the
tubulin genes and other genes involved in microtubule
function. Here we interpret ALF1 function in the context
of tubulin biogenesis and regulation.
Physical Interactions of Alf1p
We examined the interactions between several of the yeast
cofactors and yeast tubulin, as well as potential interac-
tions between the cofactors themselves. First, in a screen
against the entire yeast genome, the two yeast a-tubulin
genes, TUB1 and TUB3, were identified as interacting
with ALF1. We confirmed this interaction by demonstrat-
ing that a-tubulin immunoprecipitates with Alf1p. Simi-
Figure 5. Localization of Alf1p-GFP to microtubules depends on
both the Alf1p CLIP-170 domain and the domains of a-tubulin
identified in the two-hybrid assay (Table V). (A) Localization of
Alf1p-GFP in living cells. Wild-type diploid cells expressing
Alf1p-GFP were examined by fluorescence microscopy. Alf1p is
present on both spindle and cytoplasmic microtubules, but the
cytoplasmic microtubules are very faint. Expression of Alf1p-
GFP was under the control of the GAL1 promoter and is induced
by growth in 2% galactose and 0.5% glucose. (B) alf1-1p-GFP
does not localize to the microtubule cytoskeleton in wild-type
cells. (C) Wild-type Alf1p-GFP does not localize to the microtu-
bule cytoskeleton in tub1-850 cells. Cells were grown in minimal
media containing 2% galactose and 0.5% glucose.
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larly, cofactor B has been shown biochemically to interact
with a-tubulin (Tian et al., 1996; 1997). In the same two-
hybrid screen, CCT5 was identified as interacting with
ALF1. Cct5p is one of the eight Cct protein subunits of the
chaperonin complex. It is proposed that the tubulin pro-
teins interact with this complex before interacting with co-
factors A-E (Gao et al., 1993), and cofactor B/Alf1p is
thought to be the first protein to bind a-tubulin after the
chaperonin complex. Thus this interaction provides a po-
tential mechanism for transfer of the monomeric a-tubulin
to the cofactor pathway.
Another important result from the two-hybrid analysis
is the lack of detectable interaction between Alf1p and the
other yeast cofactors in direct pairwise tests. Alf1p did not
interact with either Cin1p or Pac2p; similarly, Cin1p and
Pac2p did not interact. Although there are many possible
reasons for the lack of an interaction in the yeast two-
hybrid system, each of the fusion proteins involved was in-
dependently able to interact with other proteins. The lack
of interactions among the cofactors is of interest because it
leaves open the questions of how the monomeric tubulin
subunits are transferred from one protein to another, and
of how they are ultimately joined to form the heterodimer.
Finally, the results we present here, in combination with
the work of others, show that the interactions of the yeast
cofactors with the tubulin proteins are the same as those of
the mammalian cofactors. Alf1p and Pac2p associate with
a-tubulin, and not b-tubulin (see Fig. 1 B; Vega et al.,
1998), whereas Rbl2p binds to b-tubulin, and not a-tubu-
lin (Archer et al., 1995, 1998). We have also found that
Cin1p interacts with b-tubulin, and not a-tubulin (Feier-
bach, B., and T. Stearns, unpublished results) The similar-
ity of these interactions with those of the mammalian pro-
teins suggests that similar pathways are operating in both
yeast and mammalian cells.
Nature of the Alf1p—a-Tubulin Interaction
The above evidence indicates that Alf1p binds to mono-
meric a-tubulin. We have identified the domains required
for this interaction on both Alf1p and a-tubulin. Alf1p
contains a single copy of the CLIP-170 domain, and muta-
Figure 6. Consequences of
overexpressing Alf1p in
cin1D cells. (A) Overexpres-
sion of ALF1 is lethal in
cin1D cells. Cooverexpres-
sion of a-tubulin rescues the
lethality of ALF1 overex-
pression in a cin1D strain.
cin1D strains bearing the in-
dicated plasmids were spot-
ted onto selective media con-
taining either 2% glucose or
2% galactose. The vectors
were pTS210 (CEN; GAL1
promoter; URA3 marker)
and pTS249 (CEN; GAL1
promoter; LEU2 marker).
(B) cin1D cells overexpress-
ing Alf1p exhibit a loss of microtubules. At time zero, cultures were resuspended at z2 3 106 cells/ml in selective medium containing
2% galactose. Samples were fixed at various time points by the addition of formaldehyde to 3.7%, and the fixed cells were stained with
YOL1/34, an anti-a-tubulin mAb (the 9 h time point is shown).
Figure 7. Overexpression of
Alf1p results in the coimmu-
noprecipitation of both a-
and b-tubulin. Alf1p-myc was
expressed from the GAL1
promoter was immunopre-
cipitated from extracts with
anti-myc mAb in the absence
(myc) or presence (myc 1
peptide) of competing anti-
genic peptide. Precipitates
were immunoblotted with ei-
ther anti-myc, anti-a-tubu-
lin, or anti-b-tubulin anti-
bodies, as indicated on the
left-hand side of the figure.
Table V. Synthetic Genetic Interactions with alf1D
Strain
Benomyl Sensitivity
ALF1 alf1D
mg/ml
Wild-type 15 5
tub1-801 2 SL
tub1-831 10 1
tub1-839 30 2
tub3D 5 2
tub2-428 2 10
tub2-408 10 2
tub2-442 80 20
bik1D 20 2
cin1D 1 ,1
pac2D 2 2
rbl2D 10 1
Double mutants were created by crosses. SL indicates that the double mutant is syn-
thetically lethal. All strains were tested on plates containing either 0, 1, 2, 5, 10, 15,
20, 30, or 80 mg/ml of benomyl. The highest concentration which exhibited growth at
258C is reported.
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tion of this domain abolishes interaction with a-tubulin.
Cofactor E/Pac2p also contains a CLIP-170 domain, and
also binds to a-tubulin (Table III; Tian et al., 1996, 1998).
Since both Pac2p and Alf1p specifically interact with a-tubu-
lin, it seems likely that the CLIP-170 domain specifically
recognizes a-tubulin. In addition, other proteins that have
a CLIP-170 domain, such as CLIP-170 and Bik1p, are
known to bind to the microtubule polymer and it is possi-
ble that these proteins are interacting with the polymer by
specifically interacting with a-tubulin. We note that the
known polymer-binding CLIP-170 proteins have not, to
our knowledge, been tested for interaction with mono-
meric tubulin, and it remains possible that they are similar
to Alf1p in their preference for monomer vs. polymer.
We used a panel of defined a-tubulin mutants to map
the Alf1p binding site on a-tubulin. The approach used
was similar to that previously used for actin and actin
binding proteins (Wertman et al., 1992; Holtzman et al.,
1994; Amberg et al., 1995), and was made possible by
the availability of a complete set of clustered charged-to-
alanine mutations in the yeast TUB1 a-tubulin gene
(Richards, 1997; Schwartz et al., 1997). We reasoned that
a-tubulin mutations that disrupted the interaction with
Alf1p in the two-hybrid assay would define the side chains
making up the interacting surface. By modeling the yeast
TUB1 a-tubulin sequence onto the mammalian a-tubulin
three-dimensional structure, we determined that the muta-
tions that disrupt the interaction fall, for the most part, on
one face of the a-tubulin three-dimensional structure. This
face would be exposed to the cytoplasm in the proposed
structure of the microtubule (Nogales et al., 1998), and is
different from that determined for the binding of b-tubu-
lin in either the heterodimer or the microtubule (Nogales
et al., 1998). Thus, this domain would be accessible to both
monomer and polymer binding proteins, consistent with
the ability of CLIP-170 domain proteins in general to bind
to the polymer. Given the proposed sequential action of
Alf1p and Pac2p, it will be interesting to determine whether
Pac2p recognizes the same site on a-tubulin.
Although Alf1p interacts only with a-tubulin monomer
under normal conditions, we found that overexpression of
Alf1p results in the coimmunoprecipitation of both a-tubu-
lin and b-tubulin. This experiment was done under condi-
tions of both mild (about fivefold, not shown) and extreme
(200-fold; Fig. 7) overexpression; in both cases there was
detectable association with b-tubulin, although much less
relative to a-tubulin under mild Alf1p overexpression con-
ditions. This result could be either direct, by interaction of
Alf1p with b-tubulin, or indirect by interaction of Alf1p
with a-tubulin in the heterodimer. The latter seems most
likely given the other evidence for the specificity of the
Alf1p-a-tubulin interaction, and that the Alf1p binding
site on a-tubulin would be accessible in both the monomer
and heterodimer.
The Yeast Cofactor Pathway
Tian et al. (1997) proposed a model of the cofactor path-
way in which the tubulin monomers interact sequentially
with the cofactors after release from the cytosolic chapero-
nin complex (c-cpn/TriC/Cct complex). In this model, co-
factors B/Alf1p and E/Pac2p interact with a-tubulin mono-
mer, and cofactors A/Rbl2p and D/Cin1p interact with
b-tubulin to promote their assembly into the heterodimer.
The interactions described here between the yeast cofac-
tors and specific tubulin monomers are entirely consistent
with this model. The alf1D pac2D double mutant is viable
and the phenotype is no more severe than the pac2D single
mutant. In contrast, the phenotypes of the alf1D cin1D and
alf1D rbl2D double mutants are more severe than either of
the single mutants. These results are consistent with Alf1p
and Pac2p acting in the same pathway and Cin1p and
Rbl2p acting in a separate pathway. However, other ge-
netic results suggest two modifications to the original
model: (a) because a-tubulin is essential for viability, and
an alf1D pac2D double mutant is viable, there must be an-
other path to functional a-tubulin; (b) because a cin1D
rbl2D strain is inviable whereas the single mutants are via-
ble, there are likely to be two independent pathways to
functional b-tubulin, one dependent on Cin1p, and the
other on Rbl2p. Both of these changes are incorporated in
a revised model of the yeast cofactor pathway, shown in
Fig. 8.
Alf1p Function
The mammalian tubulin cofactor proteins have been pro-
posed to be tubulin monomer binding proteins that facili-
tate the formation of the tubulin heterodimer (Tian et al.,
1997). Our results with ALF1 are consistent with this hy-
pothesis: Alf1p binds to monomeric a-tubulin, the alf1 null
mutant is supersensitive to benomyl, as expected for a re-
duction in the amount of functional tubulin heterodimer,
and the ALF1 overexpression phenotype suggests that
Alf1p can sequester a-tubulin monomer. One of the issues
regarding cofactor function is whether the proteins are re-
quired for the folding of the tubulin monomers, or acting
as assembly factors, bringing together two fully folded tu-
bulin monomers to make the heterodimer. Several of our
results bear on this issue. First, the level of a-tubulin
protein is the same in alf1 and wild-type cells. If there
were significant amounts of partially folded a-tubulin, one
might expect to observe decreased a-tubulin levels due to
protein turnover. Similarly, the alf1D phenotype with re-
spect to genetic interactions with tub2-428 is distinct from
that of deletion of the minor a-tubulin gene TUB3, sug-
gesting that the afl1D defect is not equivalent to a reduc-
tion of a-tubulin levels. Second, Alf1p can bind to mi-
Figure 8. Model of the cofac-
tor pathway in yeast, adapted
from Tian et al. (1997). In
this model, a- and b-tubulin
are released from chaperonin
complexes and interact with
monomer-specific cofactors
before formation of the tubu-
lin heterodimer. a-Tubulin
can become functional either
by complexing with Alf1p
and Pac2p, or via a putative
alternate pathway. b-Tubu-
lin can become functional by interaction with either Rbl2p or
Cin1p. The pathways converge at the point of a-b-heterodimer
formation.
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crotubule polymer, which must represent native tubulin.
In addition, overexpressed Alf1p can immunoprecipitate
both a- and b-tubulin; this seems most likely to be due to
association with the heterodimer, again suggesting that
Alf1p can interact with native a-tubulin. The ability to as-
sociate with native tubulin might be common to all of the
cofactors. For example, cofactors B and C (no known ho-
mologue in yeast) and cofactor E/Pac2p have been shown
to behave as microtubule-associated proteins in vitro
(Tian et al., 1996), and the cofactor D/Cin1p homologue in
Schizosaccharomyces pombe, alp11, also localizes to mi-
crotubules in vivo (Hirata et al., 1998).
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